In addition, CYP2C19*2 (rs4244285; 681G>A) and CYP2C19*3 (rs4986893; 636G>A) are associated with changes in the volume of distribution and plasma concentrations of VPA and its metabolites in patients with epilepsy. Here, CYP2C19 is linked to epilepsy.